The Board of Management of Deutsche Telekom AG plans to propose to the annual shareholder meeting to increase the dividend for the 2024 financial year to 0.90 euros per dividend-bearing share, up from ...

Relief Therapeutics Announces Promising Preliminary Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa ...

As part of this transaction, ElringKlinger AG will recognize non-cash impairment losses in the mid to high double-digit million euro range as of the end of the third quarter of 2024. These relate ...

17:40 AEVIS VICTORIA SA – Sw. 17:40 AEVIS VICTORIA SA – Sw. 13:30 EQS-Adhoc: Nakiki SE: Lett. 13:30 EQS-Adhoc: Nakiki SE: Lett. 12:30 EQS-Adhoc: Shelly Group an. 12:30 EQS-Adhoc: Shelly Group ve.

07.10.24 AL Trust Euro Short Term-Fonds: Wertzuwachs von 3,0% im laufenden Jahr - Fondsanalyse (1845 Klicks) ...

01.10 EQS-Adhoc: Covestro AG: C. 01.10 EQS-Adhoc: Covestro AG: C. 01.10 EQS-WpÜG: Takeover Offer. 01.10 EQS-WpÜG: Übernahmeange. 01.10 Leclanché SA: Announces E ...

Relief Therapeutics Reports Positive Results from RLF-OD032 Proof-of-Concept Clinical Study for Phenylketonuria ...

01.10 EQS-Adhoc: KAP AG STR. 01.10 EQS-Adhoc: KAP AG STR. 01.10 EQS-Adhoc: Heidelberg Phar. 01.10 EQS-Adhoc: Heidelberg Phar. 01.10 EQS-Adhoc: DWK Deutsche. 01.10 EQS ...

Change in Forecast/Development of Sales Gerresheimer AG: Adjustment of growth guidance for 2024 and 2025 30-Sep-2024 / 16:21 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the ...

01.10 EQS-Adhoc: GBK Beteiligung. 01.10 EQS-Adhoc: Springer Nature. 01.10 EQS-Adhoc: Springer Nature. 01.10 EQS-Adhoc: KAP AG STR. 01.10 EQS-Adhoc: KAP AG STR. 01.10 EQS-Adhoc: Heidelberg Phar.

30.09 Xlife Sciences AG ermöglich. 30.09 EQS-Adhoc: flatexDEGIRO s. 30.09 EQS-Adhoc: flatexDEGIRO l. 30.09 EQS-Adhoc: ARI Motors Ind. 30.09 EQS-Adhoc: aconnic AG ve. 30.09 EQS-Adhoc: aconnic AG pu.